# Sources — Madam C. J. Walker

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 4, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. Indiana Historical Society. “Madam C.J. Walker” (Famous Hoosiers). Supports her birth as Sarah Breedlove in Delta, Louisiana, on December 23, 1867, to Owen and Minerva Anderson Breedlove, both formerly enslaved; her hair loss, which the page attributes to poor hygiene, diet and scalp diseases such as dandruff, shared by many Black women of the time; the laboratory and beauty school in Indianapolis in 1910 and several thousand agents; gifts to Tuskegee Institute and the NAACP; the 1915 lawsuit over theater discrimination; that “she developed health problems, including high blood pressure and kidney failure”; her illness on a trip to St. Louis in April 1919; and her death on May 25, 1919, at Villa Lewaro. https://indianahistory.org/education/educator-resources/famous-hoosiers/madam-c-j-walker/
2. Jeansonne G, Luhrssen D. “Madam C. J. Walker,” *64 Parishes* (Louisiana Endowment for the Humanities). Supports her birth on December 23, 1867, in Delta; her parents’ enslavement on a Madison Parish plantation; that both parents had died by the time she was seven; marriage at fourteen and widowhood at twenty; work as a washwoman and cook; the sulfur ointments for scalp disease “inspired by her own hair loss”; her marriage to Charles Joseph Walker in 1906 and her keeping the name after the divorce; more than twenty thousand agents by 1919 by her report; her move to Villa Lewaro (dated 1917 here) and her death there on May 25, 1919. https://64parishes.org/entry/madam-c-j-walker
3. McNatt M. “Madam C. J. Walker’s Rags to Riches Story Found in the Holdings of the National Archives,” U.S. National Archives, July 22, 2021. Supports that she was her parents’ first child born into freedom, orphaned at seven, moved to Vicksburg, married at fourteen, widowed by twenty, worked as a laundress for as little as a dollar a day, suffered “hair ailments including baldness,” married Charles Joseph Walker (dated 1905 here), and in 1917 joined the committee of the Negro Silent Protest Parade in petitioning the President and Congress that lynching be made a national crime. https://prologue.blogs.archives.gov/2021/07/22/madam-c-j-walkers-rags-to-riches-story-found-in-the-holdings-of-the-national-archives/
4. National Women’s History Museum. “Madam C.J. Walker.” Supports her parents as formerly enslaved sharecroppers, orphaned at seven, the laundress years, hair loss, joining Annie Turnbo Malone’s sales agents in 1904, her own line in Denver, the Indianapolis factory, gifts to the YWCA, Tuskegee tuition and $5,000 to the NAACP’s anti-lynching work, and that she was dying of kidney failure at the end of her life. https://www.womenshistory.org/education-resources/biographies/madam-cj-walker
5. “Walker, Madame C.J. (1867–1919),” *Women in World History: A Biographical Encyclopedia* (Gale), on Encyclopedia.com, drawing on A’Lelia Bundles’s biographies. Supports that her “hair was split and her scalp was balding in patches,” attributed to poor nutrition, a hard life and harsh treatments; the marriage on January 4, 1906; that she began calling herself Madame Walker to evoke glamour and avoid homely names such as “Aunt Sarah”; the Pittsburgh headquarters and agent school in 1908; that “the physical demands that Walker placed on herself undermined her health, and she suffered from hypertension”; rest cures at Hot Springs, Arkansas, in 1916 and at Battle Creek Sanitarium in 1917; that otherwise “she did not relax her pace”; her grave illness in St. Louis in April 1919; and death of “chronic interstitial nephritis” at Villa Lewaro on May 25, 1919, at 51. https://encyclopedia.com/women/encyclopedias-almanacs-transcripts-and-maps/walker-madame-cj-1867-1919
6. Lemelson Center for the Study of Invention and Innovation. “Madam Walker.” Supports her birth to formerly enslaved parents, her own hair loss and the scalp disease her products treated, her thousands of agents, and her death on May 25, 1919, at 51 “from kidney failure.” https://lemelson.mit.edu/resources/madam-walker
7. Bundles A. *On Her Own Ground: The Life and Times of Madam C. J. Walker* (Scribner, 2001), chapter 17, “We Should Protest,” as quoted in the Wikipedia article on her: “By mid-November 1917, Dr. George Sauer, a Chicago physician, had braced her for unwanted news. His diagnosis: nephritis, an acute, and often irreversible, inflammation of the kidneys exacerbated by her worsening hypertension. He advised that she check into Michigan’s celebrated Battle Creek Sanitarium for ‘an indefinite stay.’” The book itself was not available; the quoted passage is used only for this diagnosis, and the Gale entry independently records the Battle Creek stay. https://en.wikipedia.org/wiki/Madam_C._J._Walker
8. Bundles A. “The Centennial of Madam C. J. Walker’s Death – May 25, 1919,” aleliabundles.com, May 2019. Supports her birth on December 23, 1867, as the first child in her family born into freedom, and her death on May 25, 1919, at Villa Lewaro, with the funeral there. https://aleliabundles.com/2019/05/
9. HISTMED Master Roster v3 (ET019). Internal project source; not treated as independent corroboration.

## Clinical guidance

1. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (PMID 40815242): standardized office measurement, out-of-office confirmation by ambulatory or home monitoring, a goal below 130/80, two first-line medicines for stage 2 hypertension, and a renin-angiotensin blocker for CKD with albuminuria. https://pubmed.ncbi.nlm.nih.gov/40815242/
2. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (PMID 38490803): chronicity over three months, GFR and albuminuria staging, the risk heat map, the KFRE, an ACE inhibitor or ARB at the maximum tolerated dose, an SGLT2 inhibitor for eGFR 20 or more with albuminuria, sick-day guidance, and statin use by age and risk. https://pubmed.ncbi.nlm.nih.gov/38490803/
3. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in CKD (PMID 33637192): a systolic target below 120 mmHg with standardized measurement when tolerated. https://pubmed.ncbi.nlm.nih.gov/33637192/
4. Inker LA et al. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race, *N Engl J Med* 2021 (PMID 34554658), and Delgado C et al., the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease (PMID 34563581). Every eGFR in the record uses the 2021 CKD-EPI creatinine equation without a race term. https://pubmed.ncbi.nlm.nih.gov/34554658/ and https://pubmed.ncbi.nlm.nih.gov/34563581/
5. 2018 AHA/ACC Multisociety Guideline on the Management of Blood Cholesterol (PMID 30586774): Pooled Cohort Equations, intermediate risk (7.5% to under 20%), CKD as a risk enhancer, moderate-intensity statin, and a lipid panel four to twelve weeks after starting. https://pubmed.ncbi.nlm.nih.gov/30586774/
6. CMID: Clinical Monitoring Intelligence Database (Aether Forge, 2026), hypertension, chronic kidney disease, hyperlipidemia and depression monographs: out-of-office confirmation, baseline ECG, echocardiogram for stage 2 or LVH, TSH at diagnosis, BMP and eGFR every six months on RAAS therapy, K and creatinine two to four weeks after starting or titrating, UACR twice yearly for G3a A2, calcium, phosphate and PTH at G3a, baseline 25-hydroxyvitamin D, yearly hemoglobin in G3, yearly KFRE and ASCVD risk, NSAID avoidance, sodium counseling, vaccination review, and PHQ-9 yearly. https://patrickrutledge.github.io/topthirty/
7. U.S. Preventive Services Task Force: A and B recommendations, depression (2023), unhealthy alcohol use (2018), breast cancer (2024), cervical cancer (2018), colorectal cancer (2021), HIV (2019) and hepatitis C (2020). https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations
8. Centers for Disease Control and Prevention. Screening and Testing for Hepatitis B Virus Infection, 2023 (PMID 36893044), and the Adult Immunization Schedule by Age. https://pubmed.ncbi.nlm.nih.gov/36893044/ and https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html
9. Medicare Preventive Services reference (Aether Forge, 2026). https://patrickrutledge.github.io/preventative_services/

## Editorial resolutions

- **Recent-death rule.** She died in 1919, so the rule does not apply. The record keeps to published biographies and adds one ordinary sick visit that bears on her medicines.
- **Name.** The display name is “Madam C. J. Walker,” the name she chose and kept. “Madam” is a title and “C. J.” are the initials of her husband Charles Joseph Walker, so splitting the display name at the last space would code “Madam C. J.” as given names. `identity.name_parts` therefore codes her legal name as given “Sarah,” family “Walker” (the Gale entry lists “Sarah Walker” among her names); FHIR `name.text` keeps the display name. The notes call her “Madam Walker,” the form of address she chose (SOC-007, linked to CLM-0004). “Walker” alone appears in other records and is not an alias; the alias “Sarah Breedlove,” her birth name, appears in no other record.
- **What could not be verified and was left out.** The National Museum of African American History and Culture pages, the New York Times obituary, and *On Her Own Ground* itself could not be read; her physicians’ words are used only through the passage quoted from the biography. A personal physician said to have attended her death, and her reported last words, appear only in a local history blog and a novel-like biography, so they are not used. No fetched source dates a diagnosis of high blood pressure in 1916: the Gale entry records hypertension and the Hot Springs rest cure in 1916 without a date for the diagnosis, and the dated diagnosis (nephritis worsened by hypertension) is November 1917. The roster note “advised to rest in 1916 to 1919” is therefore represented by CLM-0006 and CLM-0007, not by a separate claim. The 1917 East St. Louis delegation to the White House is not used, since the fetched National Archives page documents only the petition.
- **Conflicts.** Her marriage to Charles Joseph Walker is dated January 4, 1906 (Gale), 1906 (64 Parishes) or 1905 (National Archives); CLM-0004 gives 1906 with the alternative. Her move to Villa Lewaro is 1917 (64 Parishes) or 1918 (other accounts); CLM-0008 keeps both. The cause of death is chronic interstitial nephritis (Gale), kidney failure (National Women’s History Museum, Lemelson Center), or high blood pressure and kidney failure (Indiana Historical Society); CLM-0009 records them together. The quoted biography passage gives 2001 (Gale) or 2002 (the edition Wikipedia cites); the source uses 2001.
- **Index age and dates.** The index visit on February 9, 2026 maps to February 9, 1917, when she was 49: the year after the Hot Springs rest cure and nine months before the November 1917 diagnosis of nephritis worsened by hypertension. The roster suggested about 48 or 49; 49 is the age at the only dated diagnosis. Synthetic date of birth December 23, 1976 (shift 109 years). The chronic-care visits on February 23, March 9, April 27 and August 17, the sick visit on April 13, the preventive visit on June 8 and the mammogram on June 22, 2026 map to the same days of 1917, before the nephritis diagnosis, the Battle Creek stay and the move to Villa Lewaro, and none falls on the July 1917 protest days. She is 49 throughout. Past medical history includes only the hair loss (1904) and the hypertension with the Hot Springs rest cure (1916); family history records only that both parents died when she was a child, cause not recorded. The nephritis claim (CLM-0007) is after the index date and is linked only to its timeline event, the kidney problems recorded at two weeks, and the referral step.
- **Synthetic clinical picture.** Hypertension is documented; its stage, the ambulatory and home readings, the left ventricular hypertrophy, retinopathy, kidney findings, laboratory values, imaging and medicines are synthetic. Following the presenting-problem pattern, intake records elevated blood pressure (R03.0) and albuminuria with reduced eGFR (R80.9), both resolved at two weeks when ambulatory monitoring confirmed stage 2 hypertension and the repeat tests, the year-old results and the ultrasound established CKD G3a A2 (I12.9 and N18.31 recorded then). The eGFR is stated as CKD-EPI 2021 without a race term in every label and note; the older CKD-EPI 2009 equation with a race coefficient would have reported about 60, which is stated once as a teaching point. The 10-year ASCVD risk (7.9%) is calculated from her synthetic values with the Pooled Cohort Equations for Black women, and the 5-year KFRE (1.6%, then 1.7%) with the 4-variable North American equation. Qualitative results (urinalysis, ECG, ambulatory monitoring, ultrasound, echocardiogram, fundi, hepatitis and HIV tests, mammogram, HPV and stool tests) appear only in note text. Height (163 cm) and weights are synthetic.
- **Race and medicine.** The record is written to avoid race-based medicine: the eGFR has no race coefficient; the first medicine is chosen for albuminuric CKD (an ARB, with the ACE inhibitor’s cough the deciding factor for a public speaker), not for her race; APOL1 genotyping is offered with counseling as her choice, explained as information that would not change treatment, and she declines for now. Her history of hair loss is told as her biographers tell it, as a condition shared by many Black women of her time, in an era of hard labor, poor diet and no indoor plumbing.
- **Work and rest, the teaching contrast.** Her documented advice was to rest; she did not slow down. In the modern episode no clinician tells her to slow down. The risks are stated plainly, the medicines are chosen and titrated to reach the goal, and the plan fits her travel: a home monitor that travels, medicines at home time across time zones, a sick-day card, video visits and laboratory days at home. Two missed laboratory checks are the realistic cost of her schedule and are recorded honestly.
- **Food.** The diet plan builds on what she eats: a salt-free version of her seasoning blend for the dishes she cooks on Sundays, smoked turkey in small amounts, ordering strategies for banquets, and water on travel days; no potassium-based salt substitutes on losartan. Her real diet was not researched; the diet history is synthetic.
- **Real people.** Her parents, her first husband, Charles Joseph Walker, her daughter, Annie Turnbo Malone (not named in claims) and Dr. George Sauer appear only in documented history. Her daughter is mentioned in the modern social history only as part of her family and has no role. No modern decision, statement or health fact is attributed to any real person.
- **Sick visit.** A same-day visit for viral gastroenteritis after a sales convention, chosen because it tests the sick-day rules for losartan and empagliflozin in CKD: she held both correctly, creatinine rose from 1.29 to 1.46 mg/dL (below the acute kidney injury threshold) and recovered, and the medicines were restarted after a day of normal eating. It insinuates no real diagnosis.
- **Preventive visit.** A periodic adult preventive visit at 49 (CPT 99396 with 99497 in plain text). Judgment calls: PCV20 because the CDC lists chronic renal failure as an indication, interpreted to include CKD G3a; hepatitis B vaccination because her screening showed no immunity; a primary HPV test and a mailed stool test, her choices to fit her travel; zoster deferred until 50; osteoporosis screening not indicated before menopause without risk factors.
- **Focused visits.** The four chronic-care follow-ups (two weeks with the consultation, four weeks, eleven weeks and six months) are documented as focused visits on the CMID hypertension, chronic kidney disease, hyperlipidemia and depression monographs, the 2025 AHA/ACC guideline, KDIGO 2024 and KDIGO 2021. One deviation row records two missed checks instead of invented results: the potassium and creatinine due two to four weeks after the losartan increase (missed on a three-week tour) and the panel planned a week after the gastroenteritis (missed on another trip). The sick-visit panel and the eleven-week results showed no harm (potassium 4.9 then 4.7 mmol/L; creatinine 1.46 then 1.31 mg/dL), and the corrective action was to book every laboratory check on a home day before trips are scheduled (INT-012). Synthetic findings introduced: the echocardiogram (mild concentric LVH, ejection fraction 60%), negative hepatitis and HIV tests, and her decision on APOL1 testing.
- **Consultation.** The nephrology referral and consultation by Desmond Achterberg, MD (a fictional consultant), on the day of the two-week visit, are **S**. The consultant answers the six referral questions in line with what the record shows afterwards: hypertensive kidney disease most likely, no biopsy; losartan titrated to 100 mg (done at four weeks) and amlodipine next (added at eleven weeks); a goal below 130/80 toward a systolic of 120 (122/76 at six months); empagliflozin without diabetes; potassium and creatinine two to four weeks after each change (once missed, see above) and then every six months; APOL1 testing offered as her choice (declined at six months); hepatitis and HIV tests (negative) and hepatitis B vaccination (given); KFRE 1.6%; and review in about six months by video, booked at the last visit.
